Medullary thyroid carcinoma (MTC) is a rare type of tumor that originates from thyroid C cells
and accounts for 2–4% of all malignant thyroid neoplasms. MTC may occur sporadically or …

Thyroid cancer comprises different clinical and histological entities. Whereas differentiated
(DTCs) malignancies are sensitive to radioiodine therapy, anaplastic (ATCs) and medullary …

Objective: To develop evidence-based recommendations for safe, effective, and appropriate
thyroidectomy. Background: Surgical management of thyroid disease has evolved …

Importance Thyroid cancer is more common in women than in men, but the associated
causes of these differences are not fully understood. Objective To compare sex-specific …

Unlike daily routine images, ultrasound images are usually monochrome and low-resolution.
In ultrasound images, the cancer regions are usually blurred, vague margin and irregular in …

Background The primary aim of this study was to evaluate the therapeutic efficacy and
outcome of 177Lu‐DOTATATE peptide receptor radionuclide therapy (PRRT) in …

Medullary thyroid carcinoma (MTC) is a neuroendocrine malignant tumor originating from
parafollicular C-cells producing calcitonin. Most of cases (75%) are sporadic while the …

Background: Management of patients with advanced medullary thyroid cancer (MTC)
remains a therapeutic challenge. The multi-tyrosine kinase inhibitors (TKIs) vandetanib and …

Background Medullary thyroid cancer (MTC) is a rare neuroendocrine tumor originating from
parafollicular C-cells. It represents 2% of all thyroid malignancies and 0.4-1.4% of all thyroid …

Background Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR),
lymphocyte-to-monocyte ratio (LMR), mean platelet volume (MPV), and platelet distribution …